Literature DB >> 15571027

The treatment of chronic anal fissure with botulinum toxin.

D Godevenos1, E Pikoulis, E Pavlakis, P Daskalakis, A Stathoulopoulos, E Gavrielatou, A Leppäniemi.   

Abstract

BACKGROUND/AIMS: The aim of this study was to evaluate the effectiveness of botulinum toxin for the treatment of uncomplicated dorsal chronic idiopathic anal fissure.
MATERIAL AND METHODS: Forty-five patients who reported post defecatory anal pain since two months or more were given a total of 20U botulinum toxin in the anal sphincter apparatus on both sides as well as below the anal fissure.
RESULTS: Thirty-seven patients received a second session of 25U botulinum toxin injection. Thirty-five patients (78%) presented completely healed anal fissure, while ten needed lateral internal sphincterotomy. All patients were followed up for 8-36 months. Two patients relapsed.
CONCLUSION: Local injection of botulinum toxin is a new and safe treatment; however, two sessions of injections are necessary to be effective and long-term follow-up to assess the recurrence rate of fissure is needed to evaluate further this method of treatment. Partial internal lateral sphincterotomy is no more the treatment of choice for chronic anal fissure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571027     DOI: 10.1080/00015458.2004.11679618

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

Review 1.  Botulinum toxin and anal fissure: efficacy and safety systematic review.

Authors:  Eugenia Yiannakopoulou
Journal:  Int J Colorectal Dis       Date:  2011-08-06       Impact factor: 2.571

2.  Pharmacological sphincterotomy for chronic anal fissures by botulinum toxin a.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-07

3.  Therapeutic properties of botulinum toxin on chronic anal fissure treatment and the patient factors role.

Authors:  Setareh Soltany; Hamid Reza Hemmati; Jafar Alavy Toussy; Dina Salehi; Parisa Alavi Toosi
Journal:  J Family Med Prim Care       Date:  2020-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.